The paper contains the generalizing results of many-year research related with using various ready-made medication forms (RMF) of human genetic-engineering
interferon-alpha 2 and of methods of its administration into the body. Extensive clinical materials were made use of to show convincingly that the most effective
therapy for
infectious diseases is ensured within a short time period and with a consequent long-term rehabilitation effect by using separate RMFs and methods of application of
interferon-alpha 2, when their impact on the lesion focus is monitored by the parameters of the cellular-and-humoral chains of the general and local immunity. It is noteworthy, that a selection of RMF adequate for an actual nosologic form or of an administration method can reduce the medication dose of
interferon-alpha 2 (thus, the incidence of complications to the
drug goes down), it can also eliminate the
influenza-like syndrome and production of
autoantibodies related with the intramuscular administration of
interferon-alpha 2, besides, it essentially prolongs the presence of
interferon-alpha 2 in the body. It is important that the application of
interferon-based preparations for
infectious diseases can eliminate, in a number of cases, the use of
antibiotics and other antibacterial drugs, it enhances the efficacy of antibacterial and
antiviral therapy within a comprehensive treatment scheme, it contributes to a higher resistance of normal flora to the action of
antibiotic and antibacterial drugs, and, finally, it arrests quicker the manifestations of
dysbacterioses of various localizations.